Pharmacological management of paracoccidioidomycosis

Expert Opinion on Pharmacotherapy

Volumn 6, Issue 3, 2005, Pages 385-397

  Shikanai Yasuda, Maria Aparecida ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Millenium Institute   (Brazil)

Author keywords

Amphotericina; Azoles; Paracoccidioides brasiliensis; Paracoccidioidomycosis; Sulfonamides; Therapy

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTACID AGENT; CIMETIDINE; COTRIMAZINE; COTRIMOXAZOLE; CYCLOSPORIN; DELAVIRDINE; ECONAZOLE; FLUCONAZOLE; INDINAVIR; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; PHENYTOIN; PYRROLE DERIVATIVE; RANITIDINE; RIFAMPICIN; SULFADIAZINE; SULFADOXINE; SULFAFURAZOLE; SULFAMETHOXYPYRIDAZINE; SULFANILAMIDE; SULFANILAMIDE DERIVATIVE; SULFONAMIDE; SULFONE; TERBINAFINE; UNINDEXED DRUG; VORICONAZOLE; WARFARIN;

ABDOMINAL PAIN; AGRANULOCYTOSIS; ANEMIA; ANOREXIA; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CHILL; CHRONICITY; COMORBIDITY; CRYSTALLURIA; DIARRHEA; DISEASE DURATION; DISEASE SEVERITY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG ERUPTION; DRUG EXCRETION; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; DRUG METABOLISM; DRUG PENETRATION; DRUG RESEARCH; DRUG TISSUE LEVEL; DRUG URINE LEVEL; FEVER; FOLLOW UP; GYNECOMASTIA; HEART ARRHYTHMIA; HEART DISEASE; HEMOLYTIC ANEMIA; HEPATOSPLENOMEGALY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERPNEA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; HYPERURICEMIA; HYPOKALEMIA; HYPOMAGNESEMIA; HYPOTENSION; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IN VITRO STUDY; JAUNDICE; KIDNEY DISEASE; KIDNEY TUBULE ACIDOSIS; LEUKOPENIA; LIBIDO DISORDER; LIVER DYSFUNCTION; LONG TERM CARE; LUNG INJURY; LYMPHADENOPATHY; MEGALOBLASTIC ANEMIA; MENSTRUAL IRREGULARITY; MORTALITY; MOUSE; NAUSEA AND VOMITING; NEUROLOGIC DISEASE; NONHUMAN; PARACOCCIDIOIDES BRASILIENSIS; PATIENT COMPLIANCE; PRURITUS; PURPURA; RAT; SOUTH AMERICAN BLASTOMYCOSIS; SOUTH AND CENTRAL AMERICA; SURVIVAL; TACHYCARDIA; TACHYPNEA; THROMBOCYTOPENIA; TREATMENT FAILURE; TREATMENT OUTCOME; VEIN THROMBOSIS;

AMPHOTERICIN B; CENTRAL NERVOUS SYSTEM FUNGAL INFECTIONS; DRUG RESISTANCE; FLUCONAZOLE; FOLLOW-UP STUDIES; HUMANS; IMMUNOCOMPROMISED HOST; ITRACONAZOLE; KETOCONAZOLE; PARACOCCIDIOIDOMYCOSIS; PYRIMIDINES; SULFONAMIDES; TRIAZOLES;

EID: 17144414537     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.6.3.385     Document Type: Article

References (75)

1. LONDERO AT: Epidemiologia. In: Paracoccidioidomicose. Blastomicose Sul-Americana. Del Negro G, Lacaz CS, Fiorillo A (Eds.) Sarvier, Edusp, São Paulo, Brazil (1982):85-96.
2. LIMA SMD, DURLACHER RR: Situação da Paracoccidioidomicose em Rondônia. Rer. Soc. Brás. Méd. Trop. (2003) 36(Suppl. 1):30. TL035.
3. COUTINHO ZF, SILVA D, LAZERA M et al.: Paracoccidioidomycosis mortality in Brazil (1980-1995). Cad Saude Publica. (2002) 18(5):1441-1454.
4. RATTO OR: Lesões pulmonares. Aspectos clínicos e funcionais. In: Paracoccidioidomicose. Blastomicose Sul-Americana. Del Negro C, Lacaz CS, Fiorillo A (Eds.). Sarvier, Edusp, São Paulo, Brazil (1992):161-170.
5. SHIKANAI-YASUDA MA, COTRIM SEGURADO AA et al.: Immunodeficiency secondary to juvenile paracoccidioidomycosis: secondary infections. Mycopathologia (1992) 129:23-28.
6. DILLON NL, SAMPAIO SA, HABERMANN MC et al.: Delayed results of treatment of paracoccidioidomycosis with amphotericin B plus sulfamides versus amphotericin B alone. Rev. Inst. Med. Trop. São Paulo (1986) 28(4):263-266.
7. MARQUES SA, DILLON NL, FRANCO MF et al.: Paracoccidioidomycosis: a comparative study of the evolutionary serologic, clinical and radiologic results for patients treated with ketoconazole or amphotericin B plus sulfonamides. Mycopathologia (1985) 89(1):19-23.
8. SHIKANAI-YASUDA MA, BENARD G, HIGAKI Y et al.: Randomized trial with itraconazole, ketoconazole and sulfadiazine in paracoccidioidomycosis. Med. Mycol. (2002) 40(4):411-417.
9. DEL NEGRO G: Tratamento. Controle de cura. Profilaxia. In: Paracoccidioidomicose. Blastomicose sul-americana. Del Negro G, Lacaz CS and Fiorilito AM, (Eds.), Sarvier, Edusp, São Paulo, Brazil (1982):271-283.
10. SAMPAIO SAP: Tratamento da blastomicose sul-americana. Biol. Acad. Nac. Med. (1962) 134(1):76-96.
11. RESTREPO A, GOMEZ I, CANO LE et al.: Post-therapy status of paracoccidioidomycosis treated with ketoconazole. Am. J. Med. (1983) 74(1B):53-57.
12. BORELLI D: Terapia de la paracoccidioidomicosis. Valor actual de los antiguos tratamientos. Rev. Arg. Micol. (1987) 9 Suppl. 1): 13-20.
13. CUCE LC, WROCLAWSKI EL, SAMPAIO SA: Treatment of paracoccidioidomycosis with ketoconazole. Rev. Inst. Med. Trop. São Paulo (1981) 23(2):82-95.
14. NEGRONI R: Azole derivatives in the treatment of paracoccidioidomycosis. Ann. NY Acad. Sci. (1988) 544 497-503.
15. VALLE ACF, WANKE B, WANKE NCF et al.: Tratamento da paracoccidiodiomicose. Estudo retrospectivo de 500 casos. Avaliação dos resultados terapêuticos com sulfanilamídicos, anfotericina B, associação sulfametoxazol/trimetoprim, cetoconazol e miconazol. An. Bras. Dermatol. (1993) 66(1):65-70.
16. MARCONDES J, MEIRA DA, MENDES RP et al.: Evaluation of the treatment of paracoccidioidomycosis with ketoconazole. Rev. Inst. Med. Trop. São Paulo (1984) 26(2):113-121.
17. NARANJO MS, TRUJILLO M, MUNERA MI et al.: Treatment of paracoccidioidomycosis with itraconazole. J. Med. Vet. Mycol. (1990) 28(1):67-76.
18. RESTREPO A, DE BEDOUT C, CANO LE et al.: Recovery of Paracoccidioides brasiliensis from a partially calcified lymph node lesion by microaerophilic incubation of liquid media. Sabouraudia (1981) 19(4):295-300.
19. BLOTTA MH, MAMONI RL, OLIVEIRA SJ et al.: Endemic regions of paracoccidioidomycosis in Brazil: a clinical and epidemiologic study of 584 cases in the southeast region. Am. J. Trop. Med. Hyg. (1999) 61(3):390-394.
20. NOUER AS: Estudo clínicoepidemiológico da paracoccidioidomicose associada ou não à síndrome da imunodeficiência humana adquirida. Dissertação Mestrado, Faculdade de Ciências Médicas, UNICAMP (1999).
21. BENARD G, DUARTE AJ: Paracoccidioidomycosis: a model for evaluation of the effects of human immunodeficiency virus infection on the natural history of endemic tropical diseases. Clin. Inf. Dis. (2000) 31(4):1032-1039.
22. GOLDANI LZ, SUGAR AM: Paracoccidioidomycosis and AIDS: an overview. Clin. Inf. Dis. (1995) 2(5):1275-1281
23. MARQUES SA, SHIKANAI-YASUDA MA: Paracoccidioidomycosis associated with immunosupression, AIDS and Cancer. In: Paracoccidioidomycosis (1st edn). Franco MF, Lacaz CS, Restrepo-Moreno A, and Del Negro G. (Eds.) CRC Press, Boca Raton, USA (1994) 30 393-405.
24. CONCEIÇÃO YTM: Paracoccidioidomicose e câncer, Freqüência da associação em estudo de necropsias. Dissert. Mestrado, Faculdade de Medicina da USP (1998).
25. FRANCO MF, MONTENEGRO VR, MENDES RP et al.: Paracoccidioidomycosis: a recently proposed classification of the clinical forms. Rev. Soc. Bras. Med. Trop. (1987) 20:129-132.
26. OLIVEIRA SJ, MAMONI RL, MUSATTI CC et al.: Cytokines and lymphocyte proliferation in juvenile and adult forms of paracoccidioidomycosis: comparison with infected and non-infected controls. Microbes Inf. (2002) 4(2):139-144.
27. MAMONI RL, NOUER SA, OLIVEIRA SJ et al.: Enhanced production of specific IgG4, IgE, IgA and TGF-beta in sera from patients with the juvenile form of paracoccidioidomycosis. Med. Mycol. (2002) 40(2):153-159.
28. JUVENALE M, DEL NEGRO GM, DUARTE AJ et al.: Antibody isotypes to a Paracoccidioides brasiliensis somatic antigen in sub-acute and chronic form paracoccidioidomycosis. J Med. Microbiol. (2001) 50(2):127-134.
29. BENARD C, ROMANO CC, CACERE CR et al.: Imbalance of IL-2, IFN-gamma and IL-10 secretion in the immunosuppression associated with human paracoccidioidomycsis. Cytokine (2001) 13 4):248-252.
30. MENDES RP, NEGRONI R, ARECHAVALA A: Treatment and control of cure. In: Paracoccidioidomycosis (1st Edn). Franco MF, Lacaz CS, Restrepo-Moreno A, Del Negro G. (Eds.) CRC Press, Boca Raton, USA (1994) 29:373-392.
31. DEL NEGRO GM, PEREIRA CN, ANDRADE HF et al.: Evaluation of tests for antibody response in the follow-up of patients with acute and chronic forms of paracoccidioidomycosis. J. Med. Microbiol. (2000) 49(1):37-46
32. SALINA MA, SHIKANAI-YASUDA MA, MENDES RP et al.: Detection of circulating Paracoccidioides brasiliensis antigen in urine of paracoccidioidomycosis patients before and during treatment. J. Clin. Microbiol (1998) 36(6):1723-1728.
33. DA SILVA SH, GROSSO DDEM, LOPES JD et al.: Detection of Paracoccidioides brasiliensis gp70 circulating antigen and follow-up of patients undergoing antimycotic therapy. J. Clin. Microbiol. (2004) 42(10):4480-4486.
34. DE ALMEIDA SM, QUEIROZ-TELLES F et al.: Anti-gp43 antibodies in the cerebrospinal fluid of patients with central nervous system involvement by paracoccidioidomycosis. Am. J. Clin. Pathol. (2002) 118(6):864-868.
35. BIALEK R, IBRICEVIC A, AEPINUS C et al.: Detection of Paracoccidioides brasiliensis in tissue samples by a nested PCR assay. J. Clin. Microbiol. (2000) 38(8):2940-2942.
36. NEGRONI R, ROBLES AM: El valor pronóstico de la prueba cutánea en paracoccidioidomicose. Med. Cutanea (1974) 6 453-458.
37. CASTRO CC, YAMAGA LYI, BENARD G et al.: MRI of Central Nervous System (CNS) in neuroparacoccidioidomycosis. VII Encontro Internacional sobre Paracoccidioidomicose. Campos de Jordão, São Paulo, Brasil (1999). C26.
38. BARRAVIERA B, MENDES, RP, PEREIRA PCM et al.: Evaluation of acetylator phenotype, renal function and serum sulfadiazine levels in patients with paracoccidioidomycosis treated with cotrimazine (a combination of sulfadiazine and trimethorpim). Mycopathologia (1989) 108:107-112.
39. LACAZ CS, ULSON CM, SAMPAIO SAP: Ação 'in vitro' da anfotericina B sobre o Paracoccidioides brasiliensi. Rev. Paul. Med. (1959) 54:357-360.
40. LACAZ CA, MINAMI PS: Ação 'in vitro' da sulfamida Ro 4-4393 sobre o Paracoccidioides brasiliensis. O. Hospital (1963) 64(3):83-87.
41. RESTREPO A, ARANGO MD: In vitro susceptibility testing of Paracoccidioides brasiliensis to sulfonamides. Antimicrob. Agents Chemother. (1980) 18(1):190-194.
42. RESTREPO A, GOMEZ I, ROBLEDO MA: Efficacy of ketoconazole in patients with recurrent paracoccidioidomycosis. Rev. Inst. Med. Trop. São Paulo (1982) 24(3):173-179.
43. RESTREPO A, TABARES CB: In vitro susceptibility of Paracoccidioides brasiliensis yeast form to antifungal agents. Rev. Inst. Med. Trop. São Paulo (1984) 26(6):322-328.
44. STEVENS DA, RESTREPO-M A, CORTES A et al.: Paracoccidioidomycosis (South American Blastomycosis): treatment with miconazole. Am. J. Trop. Med. Hyg. (1978) 27(4):801-807.
45. HAHN RC, MORATO CONCEICÃO YT et al.: Disseminated paracoccidioidomycosis: correlation between clinical and in vitro resistance to ketoconazole and trimethoprim sulphamethoxazole. Mycoses (2003) 46(8):342-347.
46. HAHN RC, FONTES CJ, BATISTA RD et al.: In vitro comparison of activities of terbinafine and itraconazole against Paracoccidioides brasiliensis. J. Clin. Microbiol. (2002) 40 8):2828-2831.
47. PETRI WA Jr: Antimicrobial agents: sulfonamides, trimethoprim-sulfamethoxazole, quinolones and agents in urinary tract agents. In: Goodman & Gilman's the pharmacological basis of therapeutics (10th edn). Hardman JG, Limbird LE, Gilman AC, (Eds.) MacGraw-Hill, New York, USA (2001) 44:1171-1188.
48. DEL NEGRO G: Peculiaridades na terapêutica das micoses sistêmicas. Rev. Ass. Med. Brasil (1985) 31(3 /4):47-51.
49. MACHADO FILHO J, MIRANDA JL: Considerações relativas à blastomicose sulamericana. Evolução, resultados terapêutcos e moléstias associados em 394 casos consecutivos. O. Hospital (1961) 60(40):21-59.
50. PADILHA-GONÇALVES A: Tratamento da blastomicose sudamericana pela sulfametoxipiridazina. O. Hospital (1959) 56 5):25-28.
51. SAMPAIO SAP: Tratamento da blastomicose sul-amerciana com anfotericina B. Tese Prof. Cat., Faculdade Medicina Universidade de São Paulo (1960):116.
52. DEL NEGRO G, SHIKANAI-YASUDA MA, NICODEMO AC et al.: Contribuição para o estudo da história natural da paracoccidioidomicose. I. Causas de reinternações. XX Congresso da Sociedade Brasileira de Medicina Tropical. Salvador, Bahia, Programa e Resumos. TL 107. p. 49.
53. LOPES C, ARMOND S: Ensaio terapêutico em casos sulfa-resistentes de blastomicose sul-americana. O. Hospital (1968) 73(4):253-263.
54. BARBOSA W, VASCONCELOS WMPV: Ação da sulfametoxazol associada ao trimetoprim na terapêutica da blastomicose sul-americana. Rev. Patol. Trop. (1973) 2:329-339.
55. PEREIRA RM, TRESOLDI AT, DA SILVA MT et al.: Fatal disseminated paracoccidioidomycosis in a two-year-old child. Rev. Inst. Med. Trop. São Paulo (2004) 46(3):127-131.
56. BARRAVIERA B, MENDES RP, MACHADO JM et al.: Evaluation of treatment of paracoccidioidomycosis. Combination of sulfadiazine and trimetoprim. Preliminary report. Rev. Inst. Med. Trop. São Paulo (1989) 31(1):53-55.
57. BENNET JE: Antimicrobial agents: antifungal agents. In: Goodman & Gilman's the pharmacological basis of therapeutics (10th edn). Hardman JG, Limbird LE, Gilman AG (Eds.) MacGraw-Hill, New York, USA (2001) 49:1295-1312.
58. RESTREPO A, GOMEZ I, ROBLEDO MA: Efficacy of ketoconazole in patients with recurrent paracoccidioidomycosis. Rev. Inst. Med. Trop. São Paulo (1982) 24(3):173-179.
59. BARRAVIERA B, MENDES, RP, PEREIRA PCM et al.: Measurement of glucose-6-phosphate dehydrogenase and glutathione reductase activity in patients with paracocciodiodomycosis treated with kitoconazole. Mycopathologia (1988) 104:87-91.
60. MCEWEN JG, PETERS GR, BLASCHKE TF et al.: Treatment of paracoccidioidomycosis with itraconazole in a murine model. J. Trop. Med. Hyg. (1985) 88(5):295-299.
61. NEGRONI R, FINQUELIEVICH JL, GOSIS AS: Comparative study of the efficiency of itraconazole and ketoconazole in the treatment of experimental paracoccidioidomycosis]. Med. Cutan. Ibero. Lat. Am. (1987) 15(6):455-460.
62. MARQUES SA: Treatment of paracoccidioidomycosis with itraconazole. Annual Rev. Biom. Sciences VIII Encontro Internacional sobre Paracoccidioidomicose., Pirenópolis, Goiás, Brazil (2002). Anais. p. 24-25.
63. TELLES FQ: Treatment of patients with paracoccidioidomycosis: new insights and approaches. Ann. Rev. Biom. Sciences VIII Encontro Internacional sobre Paracoccidioidomicose. Pirenópolis, Goiás, Brazil (2002). Anais. p. 26-27.
64. VILLA LA, TOBON A, RESTREPO A et al.: Central nervous system paracoccidioidomycosis. Report of a case successfully treated with itraconazole. Rev. Inst. Med. Trop. Sao Paulo (2000) 42 4):231-234.
65. MOURA LP, RAFFIN CN, DEL NEGRO GM et al.: Paracoccidioidomycosis evidencing spinal cord involvement treated with success by fluconazole. Arq. Neuropsiquiatr. (1994) 52 1):82-86.
66. OLLAGUE JM, DE ZURITA AM, CALERO G: Paracoccidioidomycosis (South American blastomycosis) successfully treated with terbinafine: first case report. Br. J. Dermatol (2000) 143(1):188-191.
67. DE CAMPOS EP, SARTORI JC, HETCH M et al.: Clinical and serologic features of 47 patients with paracoccidioidomycosis treated by amphotericin B. Rev. Inst. Med. Trop. São Paulo (1984) 26 4):212-217.
68. ERIKSSON U, SEIFERT B, DVHSGGNER S: Comparison of effects of amphotericn B desoxycholate infused over 4 or 24 hours: randomized controlled trial. Br. Med. J. (2004) 322:579-582.
69. DIETZE R, FOWLER VC JR, STEINER TS et al.: Failure of amphotericin B colloidal dispersion in the treatment of paracoccidioidomycosis. Am. J. Trop. Med. Hyg. (1999) 60 5):837-839.
70. WANKE B, PEDROSA PN, BRETAS GS et al.: Combination of rifampicin with amphotericin B in the treatment of paracoccidioidomycosis. Results in 3 treated patients. Rev. Inst. Med. Trop. São Paulo (1984) 26(4):205-211.
71. NETO AML: Neuroparacoccidioidomicose. Análise clínica de 33 casos. Tese Doutorado, Faculdade de Medicina da USP (1994).
72. SOBEL JD: Practice guidelines for the treatment of fungal infections. For the Mycoses Study Group. Infectious Diseases Society of America. Clin. Inf. Dis. (2000) 30(4):652.
73. SCAVONE R, BURGER E: Paracoccidioidomycosis: reduction in fungal load and abrogation of delayed-type hypersensitivity anergy in susceptible inbred mice submitted to therapy with trimethoprim-sulfamethoxazole. Med. Microbiol. Immunol. (Berl.) (2004) 193(1):53-59.
74. MEIRA DA, PEREIRA PC, MARCONDES-MACHADO J et al.: The use of glucan as immunostimulant in the treatment of paracoccidioidomycosis. Am. J. Trop. Med. Hyg. (1996) 55 5):496-503.
75. TABORDA CP, JULIANO MA, PUCCIA R et al.: Mapping of the T-cell epitope in the major 43-kilodalton glycoprotein of Paracoccidioides brasiliensis which induces a Th-1 response protective against fungal infection in BALB/c mice. Inf. Immun. (1998) 66 2):786-793.